Partner at Asabys, Sylvain joined the firm at its inception in 2018. At Asabys, Sylvain is involved in the sourcing, execution, and management of our investments in the biopharma and medtech segments. He currently serves on the board of directors of Anaconda Biomed, Orikine Bio and Gradient Denervation Technologies and is an observer on the boards of SpliceBio and Medlumics.
Previously, Sylvain spent a decade in academic labs both in France and the US, working in the field of gene therapy and regenerative medicine. He was a postdoctoral fellow in the department of Genetics and Genomic Sciences at the Mount Sinai School of Medicine in New York following the completion of his doctoral thesis at INSERM.
Sylvain obtained his Ph.D. in Molecular Medicine from University of Nantes, holds a master’s degree in biotechnology with honors from University Paris XII, and an MBA from Esade Business School in Barcelona.
